Cargando…
Liver-specific drug delivery platforms: Applications for the treatment of alcohol-associated liver disease
Alcohol-associated liver disease (ALD) is a common chronic liver disease and major contributor to liver disease-related deaths worldwide. Despite its pre-valence, there are few effective pharmacological options for the severe stages of this disease. While much pre-clinical research attention is paid...
Autores principales: | Warner, Jeffrey Barr, Guenthner, Steven Corrigan, Hardesty, Josiah Everett, McClain, Craig James, Warner, Dennis Ray, Kirpich, Irina Andreyevna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521517/ https://www.ncbi.nlm.nih.gov/pubmed/36185629 http://dx.doi.org/10.3748/wjg.v28.i36.5280 |
Ejemplares similares
-
Soluble Epoxide Hydrolase Inhibition in Liver Diseases: A Review of Current Research and Knowledge Gaps
por: Warner, Jeffrey, et al.
Publicado: (2020) -
Fpr2(−/−) Mice Developed Exacerbated Alcohol-Associated Liver Disease
por: Hardesty, Josiah E., et al.
Publicado: (2023) -
Linoleic Acid‐Derived Oxylipins Differentiate Early Stage Alcoholic Hepatitis From Mild Alcohol‐Associated Liver Injury
por: Warner, Dennis, et al.
Publicado: (2021) -
Human Beta Defensin 2 Ameliorated Alcohol-Associated Liver Disease in Mice
por: Warner, Jeffrey B., et al.
Publicado: (2022) -
Rodent Models of Alcoholic Liver Disease: Role of Binge Ethanol Administration
por: Ghosh Dastidar, Shubha, et al.
Publicado: (2018)